Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Viladomiu

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|May 16, 2002
Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis CF J Castro, J I Esteban, A Juárez, et al.
Hepatology (Baltimore, Md.)|August 1, 1995
Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trialA González, J I Esteban, P Madoz, et al.
The New England Journal of Medicine|June 27, 1996
Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infectionC Conry-Cantilena, M VanRaden, J Gibble, et al.
Lancet (London, England)|August 5, 1989
Hepatitis C virus antibodies among risk groups in SpainJ I Esteban, R Esteban, L Viladomiu, et al.
Annals of Internal Medicine|September 15, 1991
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virusJ I Esteban, J C López-Talavera, J Genescà, et al.
The New England Journal of Medicine|October 18, 1990
Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitisJ I Esteban, A González, J M Hernández, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|May 16, 2002
Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis CF J Castro, J I Esteban, A Juárez, et al.
Hepatology (Baltimore, Md.)|August 1, 1995
Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trialA González, J I Esteban, P Madoz, et al.
The New England Journal of Medicine|June 27, 1996
Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infectionC Conry-Cantilena, M VanRaden, J Gibble, et al.
Lancet (London, England)|August 5, 1989
Hepatitis C virus antibodies among risk groups in SpainJ I Esteban, R Esteban, L Viladomiu, et al.
Annals of Internal Medicine|September 15, 1991
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virusJ I Esteban, J C López-Talavera, J Genescà, et al.
The New England Journal of Medicine|October 18, 1990
Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitisJ I Esteban, A González, J M Hernández, et al.
Pageof 2